Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer—Does pT0 Predict Better Survival than pTa/Tis/T1?

Homayoun Zargar, Kamran Zargar-Shoshtari, Yair Lotan, Jay B. Shah, Bas W. van Rhijn, Siamak Daneshmand, Philippe E. Spiess, Peter Black, Adrian S. Fairey, Laura S. Mertens, Simon Horenblas, Colin P. Dinney, Maria C. Mir, Cesar E. Ercole, Andrew J. Stephenson, Laura Maria Krabbe, Michael S. Cookson, Niels Erik Jacobsen, Daniel A. Barocas, Joshua GriffinJeff M. Holzbeierlein, Jeffrey S. Montgomery, Todd M. Morgan, Nikhil Vasdev, Andrew C. Thorpe, Jonathan Aning, Evan Y. Yu, Jonathan L. Wright, Evanguelos Xylinas, Nicholas J. Campain, Farshad Pourmalek, John S. McGrath, Wassim Kassouf, Marc A. Dall'Era, Jo An Seah, Srikala S. Sridhar, Pranav Sharma, Shahrokh F. Shariat, Scott North, Petros Grivas, Nilay Gandhi, Trinity J. Bivalacqua

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint Dive into the research topics of 'Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer—Does pT0 Predict Better Survival than pTa/Tis/T1?'. Together they form a unique fingerprint.

Medicine & Life Sciences